Astrocyte Pharmaceuticals完成950万美元B轮融资，推进AST-004二期临床

Astrocyte Pharmaceuticals宣布完成950万美元B轮融资，由DeepWork Capital领投，现有投资者继续支持，MintPharma Capital、Waterstar Capital、Dynagrow Capital和Angel Star Ventures参与。 公司：Astrocyte Pharmaceuticals 相关资产：AST-004 适应症：脑震荡、创伤性脑损伤、急性缺血性卒中 阶段：Phase 2 融资性质：股权 来源：BioSpace · Funding（https://www.biospace.com/press-releases/astrocyte-pharmaceuticals-secures-9-5-million-series-b-to-advance-phase-2-clinical-development-of-breakthrough-tbi-and-concussion-therapy-ast-004）